The Top Three Strategies the Pharmaceutical Industry Must Implement to Solve its Skills Troubles
An analysis of pharmaceutical talent trends has revealed that the industry must address the looming skills shortages or risk losing the best candidates to other sectors.
An analysis of pharmaceutical talent trends has revealed that the industry must address the looming skills shortages or risk losing the best candidates to other sectors.
According to the latest market research from specialist Life Sciences recruiter, Clinical Professionals, there are three key strategies the industry must implement to stay ahead in the talent crisis:
- Smart pipelining and pooling: In an increasingly competitive talent environment, it’s vital to build a pool of talent that matches future demand. Working with your CRO or a Functional Services Provider (FSP) can help develop a pipeline of engaged candidates, but don’t forget to make the most of digital innovations as well.
- Reaching out to new communities: Where talent comes from should not be limited to the usual sources. Businesses in the sector need to look at wider communities that may harbor future pharmaceutical talent. Graduates looking to develop their career as a physician, for example, could be future candidates for the Clinical Research, Medical Affairs and Pharmacovigilance arenas.
- Think global, not local: The talent pipeline is now internationally available and should be utilized, particularly for an industry with limited available skills. Businesses in the sector must be engaging with talent across borders using a strong employer brand message.
Yvette Cleland, Managing Director at Clinical Professionals commented on this potential skills shortage. “The upheaval the industry has noted isn’t surprising given the challenges most organizations have faced, from clinical trials failing to clients demanding more. But while the changing pharma environment and budget constraints can’t always be helped, it’s important that the people element of business isn’t pushed to one side. At the end of the day, it is this talent that really places organisations ahead of the competition.”
“Regardless of the solution organizations opt for, what is vital is that the industry gets talent back at the top of its agenda. Without the highly skilled people to drive innovation and clinical research, the pharmaceutical sector will struggle to progress.” She continued.
For more information visit www.clinicalprofessionals.co.uk
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
